ARCHIVES

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

This article is from The Cancer Letter archive.

Vol. 05 No. 28 | July 13, 1979

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Three researchers share Paul Marks Prize.

November 11, 2005

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

Funding Opportunities: ACS Calif. Division Calls for Applications

August 1, 1997

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988